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National University College of Medicine, Seoul, Korea
Background/Aims: Many studies have investigated angina and its relationship with chronic obstructive pulmonary 
disease (COPD). However, angina was diagnosed only by noninvasive tests or only by clinical symptoms in most of 
these studies. The aim of this study was to compare the prognosis, including rate of hospitalization and death from 
significant coronary artery lesion and nonsignificant coronary artery lesion angina, in patients with COPD.
Methods: Patients with COPD who underwent coronary angiography (CAG) due to angina were reviewed 
retrospectively at a tertiary referral hospital. COPD is defined as post-bronchodilator forced expiratory volume in 1 sec/
forced vital capacity (FEV1/FVC) of < 70%. A significant coronary lesion is defined as at least 50% diameter stenosis of 
one major epicardial artery in CAG.
Results: In total, 113 patients were enrolled. Mean follow-up duration was 39 ± 21 months. Of the patients, 52 (46%) 
had mild COPD and 48 (42%) had moderate COPD. Sixty-nine (61%) patients had significant stenosis in CAG. The 
death rate in the follow-up period was 2.21 per 100 patient-years. No significant difference was observed among the 
all-cause mortality rate, admission rate, or intensive care unit admission rate in patients who had COPD with or without 
significant coronary artery disease. Pneumonia or acute exacerbation of COPD was the most common cause of 
admission.
Conclusions: In patients having COPD with angina who underwent CAG, no significant difference was observed 
in mortality or admission events depending on the presence of a significant coronary artery lesion during the 2-year 
follow-up period.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is the 
fourth most common cause of the death in the United 
States and is projected to be the third most common 
cause of death by 2020 [1]. COPD and cardiovascular 
disease are two of the leading causes of morbidity and 
mortality in the United States. Several studies have 
shown associations between COPD and angina, and 
COPD with angina increases hospital admission rate 
and mortality [2]. Determining the clinical significance 
of angina as a comorbidity is important in patients with 190    The Korean Journal of Internal Medicine Vol. 27, No. 2, june 2012
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COPD because age distribution, risk factors, and clini-
cal manifestations are similar under both conditions. 
Symptoms related to angina, such as chest discomfort, 
chest pain, and dyspnea on exertion, are also com-
monly reported symptoms in patients with COPD and 
their presentation could be misinterpreted as COPD 
symptoms [3], and such patients with angina symptoms 
need cardiac evaluations. However, a noninvasive test 
can be problematic in these patients. Exercise tests, like 
treadmill tests, may not be performed due to ventilatory 
limitations in exercise and may not give satisfactory 
results. Pharmacological stress tests may be associated 
with bronchospasm [4,5]. Thus, coronary angiography 
(CAG) is the appropriate method for evaluating patients 
with COPD who also have angina symptoms. Many 
studies have examined angina and prognosis in patients 
with COPD. However, in those studies, the diagnoses of 
angina were made on clinical grounds or based on non-
invasive tests rather than angiography [6-8].
The aim of this study was to evaluate the prognosis, 
including rates of hospitalization and death with signifi-
cant coronary artery lesions and nonsignificant coro-
nary artery lesions, in patients with COPD.
METHODS
Study population
We retrospectively reviewed medical records of 134 
patients who had undergone CAG between January 
2005 and December 2010 at Seoul National University 
Hospital, a tertiary referral hospital. All patients were 
≥ 40 years of age, had smoking histories or were cur-
rent smokers, and underwent pulmonary function tests. 
Patients with no history of smoking were excluded. Pa-
tients with a previous history of myocardial infarction, 
percutaneous coronary intervention (PCI), coronary 
artery bypass graft (CABG), lung cancer, or any other 
malignancy with lung metastasis, underlying interstitial 
lung disease, and pre-operation workup CAG were also 
excluded. In total, 113 patients were enrolled for analy-
sis (Fig. 1). Our study was approved by the institutional 
review board of Seoul National University Hospital.
Definitions and methods
COPD was defined according to the Global Initiative 
for Chronic Obstructive Lung Disease (GOLD) guide-
lines, with a post-bronchodilator forced expiratory vol-
ume in 1 sec/forced vital capacity (FEV1/FVC) ratio of 
< 70%. COPD severity was graded as mild (FEV1 > 80% 
predicted), moderate (FEV1, 50-80% predicted), severe 
(FEV1, 30-50% predicted), or very severe (FEV1 < 30% 
predicted). According to the GOLD, a clinical diagnosis 
of COPD should be considered in any patient who has 
dyspnea, chronic cough or sputum production, and/or 
a history of exposure to risk factors for the disease. The 
diagnosis should be confirmed by spirometry. Angina 
symptoms include retrosternal pressure, chest pain, or 
tightness worsened by exertion and relieved by rest or 
nitroglycerin. Sudden aggravation of dyspnea that could 
not be explained by COPD was also included in angina 
symptoms. All patients underwent an examination by a 
cardiologist at least once and were followed for at least 
6 months as an outpatient.
CAG was performed after clinical evaluation by at 
least one specialized cardiologist. Significant coronary 
artery disease was defined as stenosis of more than 50% 
of the diameter at one or more major epicardial artery. 
The number of vessels with significant stenosis was 
counted and classified as 0-, 1-, 2-, or 3-vessel disease.
Major prognostic indicators included assessment of 
mortality and hospitalization rates. All-cause mortality 
and cause-specific mortality were investigated. In the 
case of death during hospitalization, the cause of death 
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Exclude  
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SNUH: COPD + CAG
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n = 134
STEMI/NSTEMI
n = 17
n = 117
Bronchiectasis n = 3
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Significant coronary stenosis
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Cancer of lung metastasis
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Figure 1. Study design. SNUH, Seoul National University 
Hospital; COPD, chronic obstructive pulmonary disease; 
CAG, coronary angiography; STEMI, ST elevation myocardial 
infarction; NSTEMI, non-ST elevation myocardial infarction; 
MI, myocardial infarction; PCI, percutaneous coronary 
intervention; CABG, coronary artery bypass graft.Park Ty, et al. Prognosis of COPD patients with coronary artery stenosis   191
http://dx.doi.org/10.3904/kjim.2012.27.2.189 http://www.kjim.or.kr
was analyzed from the death certificate written by the 
physician in charge and for patients who died outside 
of Seoul National University Hospital, it was analyzed 
by the death certificate from Statistics Korea. Causes of 
death were classified as respiratory-related death, car-
diac death, sudden death, and other causes. Admissions 
due to cardiovascular, pulmonary, and cerebrovascular 
problems were included for analysis and other reasons, 
such as elective admission for CAG, were excluded. We 
analyzed clinical characteristics including age, gender, 
body weight, height, pulmonary function test, smoking 
history, follow-up duration, admission rate, intensive 
care unit (ICU) admission rate, and mortality rate, de-
pending on the presence of a significant coronary artery 
lesion.
Statistical analysis
Quantitative variables are expressed as mean ± SD, 
and qualitative variables as numbers and percentages. 
Differences between independent groups were assessed 
by t tests for quantitative data and chi-square tests for 
qualitative variables. Mortality and admission rate de-
pending on significant coronary lesion were analyzed 
by the Kaplan-Meier method. All statistical analyses 
Table 1. Baseline characteristics of study patients 
No significant lesion 
(n = 44)
Significant lesion
(n = 69)
Total patients
(n = 113)
p value
Age, yr  67.07 ± 7.80 68.84 ± 7.61  68.15 ± 7.78 0.235
Male        42 (96)       64 (93) 0.561
Height, cm  166.23 ± 5.94  162.51 ± 21.47   163.96 ± 17.22 0.265
Weight, kg 65.84 ± 14.06 64.59 ± 9.50    65.08 ± 11.45 0.575
Body mass index, kg/m
2 23.68 ± 4.19 23.41 ± 4.26   23.51 ± 4.22 0.741
Smoking 0.692
Current smoker       20 (45)       34 (49)       54 (48)
Ex-smoker        24 (55)       35 (51)       59 (52)
Pack-yr  38.95 ± 21.51 38.95 ± 21.51 38.27 ± 20.54 0.780
Comorbidities
DM         6 (14)       16 (23)       22 (19) 0.211
Hypertension       21 (48)       42 (61)       63 (56) 0.170
CHF         1 (2) 7 (10)         8 (7) 0.112
Arrhythmia          8 (18) 7 (10)       15 (13) 0.220
Stroke          1 (2) 7 (10)         8 (7) 0.112
PFT
FEV1
a, L   1.95 ± 0.64   1.88 ± 0.67   1.90 ± 0.66 0.604
FEV1
a, pred %  75.74 ± 22.04 75.84 ± 20.07 75.80 ± 20.74 0.980
FEV1/FVC, L 55.48 ± 11.80 55.65 ± 11.70 55.58 ± 11.69 0.939
GOLD criteria
b 0.275
Mild        34 (49)        18 (41)       52 (46)
Moderate       29 (42)       19 (43)       48 (42.5)
Severe         6 (9)         4 (9)       10 (8.8)
Very severe          0 (0)         1 (2)         1 (0.9)
Values are presented as mean ± SD or number (%). 
DM, diabetes mellitus; CHF, congestive heart failure; PFT, pulmonary function test; FEV1, forced expiratory volume in 1 sec; % pred, % 
predicted; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease.
aTwo cases of FEV1 values in the no significant lesion group were not checked.
bMild (FEV1 > 80% predicted), moderate (FEV1, 50-80% predicted), severe (FEV1, 30-50% predicted), and very severe (FEV1 < 30% 
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were performed using the SPSS version 19.0 (SPSS Inc., 
Chicago, IL, USA). A two-tailed p value of < 0.05 was 
considered to indicate statistical significance.
RESULTS
In total, 113 patients were enrolled: 106 (93%) were 
men and the mean age was 68.15 ± 7.80 years. Mean 
follow-up duration was 39 ± 21 months and the total 
amount of person-time was 588 person-years. Mean 
FEV1 was 1.91 ± 0.66 L (predicted 75.8 ± 20.74%). Most 
of the patients had mild or moderate COPD (88%). 
Baseline demographic and clinical characteristics of 
patients with and without significant coronary lesions 
are summarized in Table 1, showing that no significant 
difference existed between the two groups.
Of the patients with COPD, 69 (61%) had significant 
stenosis on CAG. Specifically, 24 patients (34.8%) 
had 1-vessel disease, 19 patients (27.5%) had 2-vessel 
disease, and 26 patients (37.7%) had 3-vessel disease. 
Among the patients with significant coronary lesions, 
40 (58.0%) received PCI treatment, 14 (20.3%) under-
went CABG and the other 15 patients (21.7%) received 
medical treatment. The patients without significant le-
sions received medical treatment only. Final diagnoses 
were chronic stable angina in 70 patients (62%), variant 
angina in 7 (6%), and stable angina in 18 (16%). In 18 
patients (16%), we could not find a definitive cause of 
chest discomfort. No significant difference was detected 
in ejection fraction based on echocardiographic find-
ings between the two groups. Pulmonary artery sys-
tolic pressure data were obtained from 58 patients and 
showed no difference between the groups (Table 2).
Thirteen patients (11.6%) died during the follow-up 
period. The rate of death during the follow-up period 
was 2.21 per 100 patient-years (3.98 per 100 patient-
years in the group with angiographic significant lesions 
and 1.10 per 100 patient-years in the group without sig-
nificant lesions). For cause-specific mortality, cause of 
death data could be obtained for only 11 patients; for the 
other two, we could not obtain cause of death data. Of 
the 11, four (36.3%) were respiratory-related deaths, five 
(45.4%) were cardiac-related deaths, one (9%) was can-
cer-related, and one (9%) was a case of sudden death. 
The causes of respiratory-related deaths were pneumo-
nia in two patients, acute respiratory distress syndrome 
in one, and acute exacerbation of COPD (AECOPD) in 
one. The causes of cardiac death were congestive heart 
failure in three patients and acute coronary syndrome 
in two. Cardiac cause of death did not differ between 
the significant lesion and no significant lesion groups (p 
Table 2. Baseline characteristics of cardiac evaluation and treatment
No significant lesion
(n = 44)
Significant lesion
a
(n = 69)
Total patients
(n = 113)
p value
Significant lesion  69 (100)
One-vessel 24 (34.8)
Two-vessel 19 (27.5)
Three-vessel 26 (37.7)
Echocardiogram 
Ejection fraction, % 54.40 ± 12.91 53.79 ± 15.02 54.03 ± 14.17 0.828
PSAP, mmHg 32.74 ± 6.314 33.62 ± 9.218 33.33 ± 8.332 0.710
Treatment 
Medical 44 (100)
b 15 (21.7) 59 (52.2)
PCI 40 (58.0) 40 (35.3)
CABG  14 (20.3) 14 (12.4)
Values are presented as mean ± SD or number (%). The number of vessels with significant stenosis was counted and classified as 0-, 
1-, 2-, or 3-vessel disease.
PSAP, pulmonary artery systolic pressure; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.
aSignificant coronary artery disease was defined as stenosis of more than 50% of the diameter at one or more major epicardial artery. 
bMedical treatment only.Park Ty, et al. Prognosis of COPD patients with coronary artery stenosis   193
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= 0.160) (Fig. 2). However, death due to acute coronary 
syndrome was seen only in the significant lesion group.
The admission rate was 10.17 per 100 patient-years in 
the group with significant lesions and 3.59 in the group 
without significant lesions. The ICU admission rates 
were 0.55 and 1.76 per 100 patient-years in patients 
with and without significant lesions. No significant dif-
ferences were observed among the all-cause mortality 
rate, admission rate, or ICU admission rate in patients 
who had COPD with or without coronary artery disease 
(Table 3).
The total number of admitted patients was 18 (16%) 
and the total number of admissions was 36 cases. 
Pneumonia or AECOPD was most common cause of 
admission, occurring in 20 (56%) cases. Acute coronary 
syndrome occurred in three (8%) cases and congestive 
heart failure in four (11%) (Fig. 3, Table 4). Six (5%) pa-
tients were admitted to the ICU: all died during follow-
up and four of them died in the hospital.
DISCUSSION
We studied 113 patients having COPD with angina 
who underwent CAG. In our study, significant coronary 
artery disease was detected in 61% of the total COPD 
patient population. In a small study, CAG was per-
formed in 60 patients over 40 years of age and ischemic 
heart disease was diagnosed in 53.3% of them [9]. Our 
study showed no statistically significant prognostic 
difference, including mortality and admission rate, in 
patients with COPD and angina depending on the pres-
ence of significant coronary artery lesions.
In patients undergoing CAG for suspicion of angina, 
the incidence of normal or near-normal coronary angio-
graphic findings varied between 10% and 30%, depend-
ing on the characteristics of the patient group studied 
[10]. Our study had a slightly higher incidence of normal 
or near-normal arteries and lower detection of signifi-
cant lesions compared with other studies examining 
patients who had angina without COPD [11]. We assume 
that it was due to the presence of endothelial dysfunc-
tion, which is associated with systemic inflammation 
and may explain angina with normal or near-normal 
coronary arteries. Patients with COPD have increased 
systemic inflammation. Thus, even if we found normal 
findings in CAG, some inflammation in those patients 
may still induce angina symptoms. Long-term cigarette 
smoking is also associated with impaired endothelium-
dependent coronary vasodilation, regardless of the 
presence or absence of atherosclerotic wall thickening 
[12]. Thus, these results are thought to be due to the 
high proportion of anatomically normal coronary an-
gina.
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Figure 2. Survival curve according to significant lesion.
Table 3. Prognosis analysis in patients who have chronic obstructive pulmonary disease with angina 
No significant lesion 
(n = 44)
Significant lesion
(n = 69)
Total patients
(n = 113)
p value
Follow-up, mon 38.41 ± 22.64 39.32 ± 20.03 38.96 ± 20.99 0.823
Mean hospital stay, day 30.33 ± 41.53 19.50 ± 22.69 21.67 ± 25.90 0.537
Admission rate, Py 3.59 10.17 0.310
Intensive care unit admission rate, Py 0.55 1.76 0.922
Mortality rate, Py 1.10 3.98 2.21 0.610
PY, 100 person-years.194    The Korean Journal of Internal Medicine Vol. 27, No. 2, june 2012
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Daly et al. [11] demonstrated that the mortality rate of 
stable angina was 1.5 per 100 patient person-years. In 
the angiography-confirmed lesion group, the mortality 
rate was 1.8 per 100 patient person-years. Many stud-
ies have demonstrated that the coexistence of COPD 
and coronary artery disease leads to high morbidity 
or mortality [6-8,13]. The mortality rate in our study 
was higher than that of prior studies in stable angina 
without COPD because of differing study populations. 
Patients with confirmed coronary lesions have a worse 
prognosis compared with those with no significant le-
sion [11,14]. Our study, however, showed no mortality or 
admission rate difference in the groups with and with-
out significant lesions. One possible explanation for the 
lack of a difference in our study may be the relatively 
short follow-up period and small study population com-
pared with other angina studies. In the Coronary Artery 
Surgery Study study, 12-year survival in 3,833 patients 
with stable angina was investigated and in the Duke 
Hospital Study, the 5-year survival rate of 2,842 stable 
angina patients was examined [15,16]. The follow-up pe-
riod in our study was 2 years, shorter than in the other 
studies. In our study, we excluded high-risk patients 
who had acute myocardial infarction or previous myo-
cardial infarction or intervention and most of the pa-
tients were those with stable angina. Additionally, as an 
important prognostic factor for cardiovascular disease, 
left ventricular systolic function in both groups was 
near-normal. The short follow-up and 2-year mortal-
ity may not adequately reflect the outcomes in patients 
with COPD and angina. Mortality rates for longer-term 
follow-up will be needed.
Questions may be raised about whether aggressive in-
tervention may increase the survival rate in the signifi-
cant stenosis group. Taken together, when these study 
Table 4. Major clinical events during the follow-up period in the overall population
No significant lesion (n = 44) Significant lesion (n = 69)
p value
No. of events
Event rate per 
100 person-yr
No. of events
Event rate per 
100 person-yr
Death
a
All-cause  4 1.10 9 3.98 0.610
Cause-specific 
Noncardiac  1 0.28 6 2.65 0.250
Cardiac  2 0.56 2 0.88 0.160
Cause of admission 
Pneumonia or AECOPD 2.49 11 4.87 0.260
PTE 0 0 1 0.44 0.468
ACS 0 0 3 1.33 0.185
CHF 3 0.83 1 0.44 0.294
Cerebrovascular disease  0 0 1 0.44 0.443
Vascular disease  0 0 2 0.88 0.296
AECOPD, acute exacerbation of chronic obstructive pulmonary disease; PTE, pulmonary thromboembolism; ACS, acute coronary 
syndrome; CHF, congestive heart failure.
aAmong the deaths, cause of death data could not be obtained for two patients.
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Figure 3. Causes of death in chronic obstructive pulmonary 
disease patients with angina. AECOPD, acute excerbation of 
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findings were compared with the treatment effects of 
drug treatment, PCI, or CABG, no particular differ-
ence was detected in chronic stable angina [17,18]. The 
majority of our study patients had chronic angina and 
whether a procedure was performed may not have sig-
nificantly affected the prognosis.
The most common causes of death were respiratory- 
and cardiac-related deaths. Cardiac death and coronary 
artery stenosis did not show a statistically significant 
association. According to other reports, the presence of 
coronary artery disease was associated with higher car-
diac mortality, but not in our study [19]. We believe the 
difference may be due to the small sample size.
The most common causes of admission during the 
follow-up period were pneumonia and AECOPD. Ad-
mission for a heart problem was the next most common 
cause. In a study of patients with COPD using National 
Hospital Discharge Survey data, the patients showed 
an increasing trend in hospitalization and mortality for 
pneumonia, congestive heart failure, and ischemic heart 
disease [7]. These results suggest that the correction of 
risk factors is important in patients with COPD.
Limitations of this study include its retrospective 
nature and the small sample size. The patients groups 
were limited to patients having COPD with angina, so 
a risk of selection bias exists. Furthermore, lung can-
cer or other malignancies with lung metastases were 
excluded, but the lung cancer incidence was difficult to 
determine. Additionally, CAG itself can be a limitation. 
Because CAG is a two-dimensional assessment method, 
the extent of a lesion may not be an accurate assessment 
in patients with moderate or diffuse coronary artery 
stenosis, and evaluating functional status in coronary 
stenosis was difficult. Regarding admissions, we only 
analyzed cases of hospital admission in one tertiary re-
ferral educational hospital.
In conclusion, the detection rate of significant coro-
nary lesion in patients having COPD with angina was 
69 (61%) and it was slightly lower than that of the stable 
angina population without COPD. The mortality rate re-
corded in our study was higher than that of prior studies 
of stable angina without COPD. However, no outcome 
difference, including mortality, was detected according 
to the existence of significant coronary lesions during a 
2-year follow-up period. 
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